{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:29Z","timestamp":1791928889920,"version":"4.3.4"},"reference-count":74,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,5,5]]},"DOI":"10.1167\/iovs.66.5.9","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T10:31:07Z","timestamp":1746441067000},"page":"9","source":"Crossref","is-referenced-by-count":4,"title":["Comparative Efficacy of Interleukin-7 and -15 Blockade in Alleviating Experimental Chronic Uveitis and Suppressing Pathogenic Memory CD4\n                    <sup>+<\/sup>\n                    T Cells"],"prefix":"10.1167","volume":"66","author":[{"given":"Qiurong","family":"Zhu","sequence":"first","affiliation":[{"name":"Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shayan","sequence":"additional","affiliation":[{"name":"Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Huckfeldt","sequence":"additional","affiliation":[{"name":"Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihe","family":"Chen","sequence":"additional","affiliation":[{"name":"Schepens Eye Research Institute of Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.12688\/f1000research.10587.1","article-title":"Recent advances in managing and understanding uveitis","volume":"6","author":"Chen","year":"2017","journal-title":"F1000Res"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000078612","article-title":"Uveitis: a potentially blinding disease","volume":"218","author":"Durrani","year":"2004","journal-title":"Ophthalmologica"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1136\/bjo.2005.067421","article-title":"Quality of life and visual function in patients with intermediate uveitis","volume":"89","author":"Murphy","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/eye.2011.255","article-title":"Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation","volume":"26","author":"Lee","year":"2011","journal-title":"Eye"},{"issue":"5\u20136","key":"bib5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00163549","article-title":"The natural history of uveitis","volume":"14","author":"Nussenblatt","year":"1990","journal-title":"Int Ophthalmol"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1001\/archopht.1962.00960030506014","article-title":"Epidemiology of uveitis. Incidence and prevalence in a small urban community","volume":"68","author":"Darrell","year":"1962","journal-title":"Arch Ophthalmol"},{"key":"bib8","first-page":"1","article-title":"The reported demography and causes of blindness throughout the world","volume":"40","author":"Goldstein","year":"1980","journal-title":"Adv Ophthalmol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0896-1549(02)00023-8","article-title":"Corticosteroids in uveitis","volume":"15","author":"Rothova","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.ophtha.2017.06.017","article-title":"Corticosteroid-related adverse events systematically increase with corticosteroid dose in noninfectious intermediate, posterior, or panuveitis: post hoc analyses from the VISUAL-1 and VISUAL-2 Trials","volume":"124","author":"Suhler","year":"2017","journal-title":"Ophthalmology"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/ICU.0b013e3281107fef","article-title":"Nonsteroidal drugs for the treatment of noninfectious posterior and intermediate uveitis","volume":"18","author":"Imrie","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0896-8411(90)90143-G","article-title":"Experimental autoimmune uveoretinitis in mice. induction by a single eliciting event and dependence on quantitative parameters of immunization","volume":"3","author":"Caspi","year":"1990","journal-title":"J Autoimmun"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1167\/iovs.10-6909","article-title":"Understanding autoimmune uveitis through animal models. The Friedenwald Lecture","volume":"52","author":"Caspi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.12-10138","article-title":"Effects of systemic and intravitreal TNF-a inhibition in experimental autoimmune uveoretinitis","volume":"54","author":"Busch","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.preteyeres.2004.06.005","article-title":"The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU)","volume":"23","author":"Dick","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ophtha.2017.12.039","article-title":"Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III","volume":"125","author":"Suhler","year":"2018","journal-title":"Ophthalmology"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/25785826.2019.1642080","article-title":"The effectiveness of adalimumab treatment for non-infectious uveitis","volume":"42","author":"Hasegawa","year":"2019","journal-title":"Immunol Med"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat Med"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1084\/jem.20071258","article-title":"Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category","volume":"205","author":"Luger","year":"2008","journal-title":"J Exp Med"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ophtha.2012.09.040","article-title":"Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials","volume":"120","author":"Dick","year":"2013","journal-title":"Ophthalmology"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ophtha.2014.12.033","article-title":"Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy","volume":"122","author":"Letko","year":"2015","journal-title":"Ophthalmology"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/ni.1698","article-title":"The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo","volume":"10","author":"McGeachy","year":"2009","journal-title":"Nat Immunol"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.ophtha.2018.05.014","article-title":"Targeting interleukin-23 in the treatment of noninfectious uveitis","volume":"125","author":"Pepple","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"bib26","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/ar2530","article-title":"Therapeutic effect of the potent IL-12\/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis","volume":"10","author":"Keino","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"100866","DOI":"10.1016\/j.preteyeres.2020.100866","article-title":"Activation of the interleukin-23\/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis","volume":"80","author":"Zhong","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ajpath.2020.09.004","article-title":"Characterization of clinical and immune responses in an experimental chronic autoimmune uveitis model","volume":"191","author":"Fan","year":"2021","journal-title":"Am J Pathol"},{"issue":"4","key":"bib29","doi-asserted-by":"publisher","first-page":"e22855","DOI":"10.1096\/fj.202202164R","article-title":"Long-lived autoreactive memory CD4+ T cells mediate the sustained retinopathy in chronic autoimmune uveitis","volume":"37","author":"Fan","year":"2023","journal-title":"FASEB J"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jaut.2016.11.003","article-title":"Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity","volume":"77","author":"Chen","year":"2017","journal-title":"J Autoimmun"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nri2580","article-title":"New insights into the regulation of T cells by gamma(c) family cytokines","volume":"9","author":"Rochman","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"630022","DOI":"10.3389\/fimmu.2021.630022","article-title":"Quantitative assessment of experimental ocular inflammatory disease","volume":"12","author":"Bradley","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"bib33","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3390\/biomedicines11072022","article-title":"Comprehensive grading system for experimental autoimmune uveitis in mice","volume":"11","author":"Shome","year":"2023","journal-title":"Biomedicines"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"6096017","DOI":"10.1155\/2021\/6096017","article-title":"Significance of hyperreflective foci as an optical coherence tomography biomarker in retinal diseases: characterization and clinical implications","volume":"2021","author":"Fragiotta","year":"2021","journal-title":"J Ophthalmol"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1167\/iovs.17-23042","article-title":"Association between soluble cd14 in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with diabetic macular edema","volume":"59","author":"Lee","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"bib36","doi-asserted-by":"publisher","first-page":"e72161","DOI":"10.1371\/journal.pone.0072161","article-title":"Comparative analysis of induced vs. spontaneous models of autoimmune uveitis targeting the interphotoreceptor retinoid binding protein","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"4193","DOI":"10.1167\/iovs.17-22436","article-title":"Quantitative characterization of autoimmune uveoretinitis in an experimental mouse model","volume":"58","author":"Li","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.4049\/jimmunol.1004019","article-title":"Autoreactive memory CD4+ T lymphocytes that mediate chronic uveitis reside in the bone marrow through STAT3-dependent mechanisms","volume":"187","author":"Oh","year":"2011","journal-title":"J Immunol"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/j.1600-6143.2006.01550.x","article-title":"Neutralizing IL-7 promotes long-term allograft survival induced by CD40\/CD40L costimulatory blockade","volume":"6","author":"Wang","year":"2006","journal-title":"Am J Transplant"},{"issue":"1-2","key":"bib40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cellimm.2014.03.017","article-title":"Combination of TACI-IgG and anti-IL-15 treats murine lupus by reducing mature and memory B cells","volume":"289","author":"Ma","year":"2014","journal-title":"Cell Immunol"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.ajpath.2020.03.016","article-title":"Aged mice exhibit severe exacerbations of dry eye disease with an amplified memory Th17 cell response","volume":"190","author":"Foulsham","year":"2020","journal-title":"Am J Pathol"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1167\/iovs.07-1390","article-title":"Upregulated IL-23 and IL-17 in Beh\u00e7et patients with active uveitis","volume":"49","author":"Chi","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"23","key":"bib43","doi-asserted-by":"publisher","first-page":"e162335","DOI":"10.1172\/jci.insight.162335","article-title":"Insights gained from single-cell analysis of immune cells in tofacitinib treatment of Vogt-Koyanagi-Harada disease","volume":"7","author":"Liu","year":"2022","journal-title":"JCI Insight"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"1007352","DOI":"10.3389\/fnmol.2022.1007352","article-title":"Identification of uveitis-associated functions based on the feature selection analysis of gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment scores","volume":"15","author":"Lu","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"104","key":"bib45","doi-asserted-by":"publisher","first-page":"104ra100","DOI":"10.1126\/scitranslmed.3002949","article-title":"Human TH17 cells are long-lived effector memory cells","volume":"3","author":"Kryczek","year":"2011","journal-title":"Sci Transl Med"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.immuni.2011.09.019","article-title":"Th17 cells are long lived and retain a stem cell-like molecular signature","volume":"35","author":"Muranski","year":"2011","journal-title":"Immunity"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.celrep.2013.03.035","article-title":"Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23","volume":"3","author":"Haines","year":"2013","journal-title":"Cell Rep"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/mi.2013.20","article-title":"Chronic dry eye disease is principally mediated by effector memory Th17 cells","volume":"7","author":"Chen","year":"2014","journal-title":"Mucosal Immunol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10753-015-0229-7","article-title":"Imbalance between Th17 cells and regulatory T cells during monophasic experimental autoimmune uveitis","volume":"39","author":"Zhang","year":"2016","journal-title":"Inflammation"},{"issue":"52","key":"bib50","doi-asserted-by":"publisher","first-page":"52ra72","DOI":"10.1126\/scitranslmed.3001107","article-title":"Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis","volume":"2","author":"Hueber","year":"2010","journal-title":"Sci Transl Med"},{"issue":"2","key":"bib51","doi-asserted-by":"publisher","first-page":"105929","DOI":"10.1016\/j.isci.2023.105929","article-title":"Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes","volume":"26","author":"Pandit","year":"2023","journal-title":"iScience"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cyto.2018.01.011","article-title":"Optimized administration of hetIL-15 expands lymphocytes and minimizes toxicity in rhesus macaques","volume":"108","author":"Bergamaschi","year":"2018","journal-title":"Cytokine"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1084\/jem.20030735","article-title":"Interleukin 7 regulates the survival and generation of memory CD4 cells","volume":"198","author":"Kondrack","year":"2003","journal-title":"J Exp Med"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"9357","DOI":"10.1073\/pnas.0400640101","article-title":"IL-7 regulates basal homeostatic proliferation of antiviral CD4+T cell memory","volume":"101","author":"Lenz","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","article-title":"Homeostasis of naive and memory T cells","volume":"29","author":"Surh","year":"2008","journal-title":"Immunity"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1084\/jem.20061805","article-title":"Antiviral CD4+ memory T cells are IL-15 dependent","volume":"204","author":"Purton","year":"2007","journal-title":"J Exp Med"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri2496","article-title":"Migration, maintenance and recall of memory T cells in peripheral tissues","volume":"9","author":"Woodland","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.oret.2017.07.020","article-title":"Number of hyperreflective foci in the outer retina correlates with inflammation and photoreceptor degeneration in retinitis pigmentosa","volume":"2","author":"Nagasaka","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1001\/jamaophthalmol.2013.1724","article-title":"Characterization of birdshot chorioretinopathy using extramacular enhanced depth optical coherence tomography","volume":"131","author":"Keane","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10792-017-0549-8","article-title":"Morphometric features on enhanced depth imaging optical coherence tomography scans in idiopathic posterior uveitis or panuveitis","volume":"38","author":"Agrawal","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"1","key":"bib62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40942-016-0034-y","article-title":"Visual response and anatomical changes on sequential spectral-domain optical coherence tomography in birdshot chorioretinopathy treated with local corticosteroid therapy","volume":"2","author":"Gobuty","year":"2016","journal-title":"Int J Retina Vitreous"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12886-018-0848-5","article-title":"Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study","volume":"18","author":"Berasategui","year":"2018","journal-title":"BMC Ophthalmol"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s13300-017-0332-x","article-title":"Dexamethasone intravitreal implant in diabetic macular edema: real-life data from a prospective study and predictive factors for visual outcome","volume":"8","author":"Chatziralli","year":"2017","journal-title":"Diabetes Ther"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1097\/IAE.0000000000001070","article-title":"Hyperreflective foci as an independent visual outcome predictor in macular edema due to retinal vascular diseases treated with intravitreal dexamethasone or ranibizumab","volume":"36","author":"Chatziralli","year":"2016","journal-title":"Retina"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"1153934","DOI":"10.3389\/fnmol.2023.1153934","article-title":"The origins of the full-field flash electroretinogram b-wave","volume":"16","author":"Bhatt","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.immuni.2009.01.007","article-title":"Hepatic interleukin-7 expression regulates T cell responses","volume":"30","author":"Sawa","year":"2009","journal-title":"Immunity"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.4049\/jimmunol.178.8.4737","article-title":"IL-7 is essential for the development and the persistence of chronic colitis","volume":"178","author":"Totsuka","year":"2007","journal-title":"J Immunol"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/gene.2010.49","article-title":"IL-7Ra confers susceptibility to experimental autoimmune encephalomyelitis","volume":"12","author":"Walline","year":"2010","journal-title":"Genes Immun"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1002\/art.27578","article-title":"Blockade of the interleukin-7 receptor inhibits collagen-induced arthritis and is associated with reduction of T cell activity and proinflammatory mediators","volume":"62","author":"Hartgring","year":"2010","journal-title":"Arthritis Rheum"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.4049\/jimmunol.171.3.1556","article-title":"Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis","volume":"171","author":"Yamazaki","year":"2003","journal-title":"J Immunol"},{"issue":"24","key":"bib72","doi-asserted-by":"publisher","first-page":"e126054","DOI":"10.1172\/jci.insight.126054","article-title":"Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes","volume":"4","author":"Herold","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"bib73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1208\/s12248-019-0401-3","article-title":"Model-based characterization of the pharmacokinetics, target engagement biomarkers, and immunomodulatory activity of PF-06342674, a humanized mAb against IL-7 receptor-a, in adults with type 1 diabetes","volume":"22","author":"Williams","year":"2020","journal-title":"AAPS J"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bcp.13748","article-title":"Anti-IL-7 receptor a monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study","volume":"85","author":"Ellis","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"bib57","first-page":"1584","article-title":"Flip the coin: IL-7 and IL-7R in health and disease","volume-title":"Nat Immunol","author":"Barata","year":"2019"}],"container-title":["Investigative Ophthalmology &amp; Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2802954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:12Z","timestamp":1791927132000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2802954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.5.9","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}